Comparison of the safety and efficacy of the combination of Wharton's jelly mesenchymal stem cells conditioned medium and platelet-rich plasma and liposomal of Wharton's jelly mesenchymal stem cells conditioned medium and platelet-rich plasma in the treatment of androgenetic alopecia
Phase 1
Recruiting
- Conditions
- Androgenetic alopecia.Androgenic alopecia, unspecifiedL64.9
- Registration Number
- IRCT20200127046282N24
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not using topical or oral medication for the treatment of alopecia during the last six months
AGA type 2-4
Exclusion Criteria
Age under18 years
pregnancy
breastfeeding
History of malignant diseases
Taking any topical or systemic treatment during the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hair density. Timepoint: Before starting the treatment, the end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Biometric examination will be done and the findings from VISIOFACE and TES-TB (hair loss type with X1 lens, hair density and scalp condition with X60Triple lens, hair diameter and PORE condition with KPL X150 lens and hair shaft surface condition with X700 lens) It will be recorded for each patient.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: One week after session. Method of measurement: Questionnaire and visit.;Satisfaction. Timepoint: One months after the last session. Method of measurement: Satisfaction Questionnaire and visit.;Tolerability. Timepoint: Each session after transplantation. Method of measurement: Questionnaire and visit.